ARWR
NASDAQ · Biotechnology
Arrowhead Pharmaceuticals In
$58.16
+0.70 (+1.22%)
Performance
1D
+0.00%
1W
-2.37%
1M
-4.25%
3M
-34.16%
6M
-25.19%
1Y
+48.25%
YTD
-14.21%
Open$58.21
Previous Close$57.46
Day High$58.71
Day Low$57.00
52W High$95.49
52W Low$37.06
Volume—
Avg Volume1.37M
Market Cap8.17B
P/E Ratio—
EPS$-2.24
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$66.91
Below
SMA 200
$71.55
Below
RSI (14)
53.6
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
21 analysts
Price Target
+19.5% upside
Current
$58.16
$58.16
Target
$69.50
$69.50
$62.98
$69.50 avg
$88.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 871.57M | 579.04M | 3.64B |
| Net Income | -1,714,711 | -1,025,272 | -138,687,526 |
| Profit Margin | -0.2% | -0.2% | -3.8% |
| EBITDA | 128.48M | 81.09M | -183,881,108 |
| Free Cash Flow | — | — | -98,110,953 |
| Rev Growth | +50.5% | +50.5% | +9.5% |
| Debt/Equity | 1.34 | 1.34 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |